News that may have an impact on prices of some stocks today, 13th August

Jindal Steel and Power’s June quarter profit down by 10%

Jindal Steel and Power Limited reported a 10% fall in its Q1 consolidated net profit at Rs 1496 crore versus Rs. 1338 crore in the year ago period. Jindal Steel and Power’s revenue from operations stood at Rs 12294 crore, down 10% from Rs 13618 crore reported in the corresponding quarter of FY25. Its margin increased to 24% from 21% across periods.

PN Gadgil Jeweller’s profit doubles in June quarter

PN Gadgil’s net profit nearly doubled in the June quarter, increasing by 96.3% from the year-ago quarter to Rs 69.3 crore. Revenue increased by 2.8% from the base quarter to Rs 1,714.5 crore. EBITDA for the quarter increased by 71.5% from last year to Rs 109.9 crore, while margins expanded by 340 basis points year-on-year to 6.4% from 3.8% last year.

Balrampur Chini Mills’ June quarter profit down by 26%

Balrampur Chini Mills Limited reported a 26% fall in its Q1 consolidated net profit at Rs 52 crore versus Rs. 70 crore in the year ago period. Balrampur Chini Mills’s revenue from operations stood at Rs 1542 crore, up 8% from Rs 1422 crore reported in the corresponding quarter of FY25. Its margin decreased to 9% from 12% across periods.

Oil India posts Rs 813.5 crore in June quarter

Oil India revenue was in line with estimates, and net profit was below expectations in Q1FY26, due to a sharp drop in crude price realisation from USD 84.89/bbl in Q1FY25 to USD 66.20/bbl in Q1FY26, a drop of 22%. Standalone revenue was down by 6% YoY to Rs 5,012 crore. EBITDA was at Rs 1606 crore in Q1FY26 vs. it was Rs 2,466 crore in Q1FY25. Oil India’s net profit stood at Rs 813.5 crore in Q1FY26.

Bharat Dynamics posts Rs 18 crore profit in June quarter

BDL’s numbers were above expectations in Q1FY26. Its consolidated revenue grew by 29.7% YoY to Rs 248 crore in Q1FY26. The company’s net profit stood at Rs 18 crore vs. Rs 7 crore in Q1FY25, supported by higher other income. Other income increased to Rs 86.9 crore in Q1FY26 vs. Rs 80.4 crore in Q1FY25. Net profit margin stood at 7.4% from 3.8% in Q1FY25.

HAL’s June quarter profit down by 3.7%

HAL revenue was inline with estimates, and net profit was below expectations in Q1FY26. Its revenue stood at Rs 4,819 crore in Q1FY26, grew 10.9% YoY. The company’s EBITDA (excl. other income) stood at Rs 1,282 crore, EBITDA increased by 29.4% YoY. EBITDA margin was at 29% in Q1FY26 vs. 22.8% in Q1FY25. The company’s net profit fell by 3.7% YoY to Rs 1384 crore in Q1FY25. Other income was at Rs 747 crore in Q1FY26 vs. Rs 736 crore in Q1FY25. Net profit margin stood at 28.7% in Q1FY26 vs. 33% in Q1FY25.

BPCL/ ONGC working on feasibility reports of their upcoming refineries

Bharat Petroleum Corporation Limited (BPCL) and Oil and Natural Gas Corporation Limited (ONGC) are currently working on detailed feasibility report (DFR) of their respective upcoming refineries in India in the next seven to eight months, post which a final decision would be taken on investment share of Saudi Arabia in these projects.

Va Tech Wabag’s June quarter profit up by 19.6%

Consolidated revenue stood at Rs 734 crore growing 17.1% YoY from Rs. 626.5 cr for Q1FY25. EBITDA was up by 17.5% YoY to Rs 95.6 crore from Rs. 81.3 cr and EBITDA margin stood at 13% in Q1FY26 vs. 12.9% in Q1FY25. Net profit stood at Rs 65.8 crore in Q1FY26 vs. Rs 55 crore in Q1FY25 (+19.6% YoY).

Transrail gets new orders of Rs 701 crore

Company bagged new orders totalling Rs 701 crore from both Indian and overseas clients, pushing its cumulative FY26 order inflow beyond Rs 2,300 crore. These orders include T&D orders in international market as well as domestic orders in Civil and Pole & Lighting verticals.

Techno Electric & Engineering posts Rs 136.1 crore profit in June quarter

Consolidated revenue stood at Rs 526 crore growing 40.1% YoY from Rs. 375.3 cr for Q1FY25. EBITDA was up by 76.5% YoY to Rs 92.3 crore from Rs. 52.3 cr and EBITDA margin stood at 17.6% in Q1FY26 vs. 13.9% in Q1FY25. Net profit stood at Rs 136.1 crore in Q1FY26 vs. Rs 98.1 crore in Q1FY25 (+38.7% YoY).

Hindalco Industries’ profit in June quarter up by 30%

Hindalco Industries reported a 30% rise in its Q1 consolidated net profit at Rs 4004 crore versus Rs. 3074 crore in the year ago period. Hindalco Industries’s revenue from operations stood at Rs 64,232 crore, up 11% from Rs 57013 crore reported in the corresponding quarter of FY25. Its margin decreased to 12% from 13% across periods.

Ritco Logistics’ profit in June quarter up by 4%

Ritco Logistics Limited reported a 4% rise in its Q1 consolidated net profit at Rs 9 crore versus Rs. 8.7 crore in the year ago period. Ritco Logistics’s revenue from operations stood at Rs 356 crore, up 41% from Rs 253 crore reported in the corresponding quarter of FY25. Its margin remained at 8% across periods.

Jyothy Labs’ June quarter profit down by 5%

Jyothy Labs reported a 5% fall in first-quarter net profit to Rs 96.8 crore, hurt by lower margins. Revenue rose 1.3% to Rs 751.2 crore, supported by 3.6% volume growth. EBITDA fell 7% to Rs 124 crore, with the operating margin narrowing to 16.5% from 18% a year earlier.

Honasa Consumer’s June quarter profit up by 2.7%

Honasa Consumer reported a 2.7% year-on-year (YoY) increase in net profit at Rs 41.3 crore for the first quarter that ended June 30, 2025. The company’s revenue from operations was up 7.4% to Rs 595.2 crore as against Rs 554 crore in the corresponding period of the preceding fiscal.

Aavas Financiers June quarter profit up by 10.4%

The Company reported 10.4% YoY growth in PAT to Rs 139 crore. NII was up 14% at Rs 278 crore vs ₹245 crore (YoY). AUM increased 16% to Rs 20740 crore. Opex to Assets ratio saw a decline of 25 bps QoQ in Q1FY26 at 3.46%. NIM during Q1FY26 stood at 7.48% up 17 bps YoY. NPA worsened during the quarter with GNPA/NNPA increasing 14/11 bps sequentially to 1.22/0.84%.

Karnataka Bank profit down by 27% in June quarter

The Bank’s PAT slid by 27% YoY to Rs 292 crore as NII fell 16% to Rs 755 crore. GNPA stood at 3.46% in the June quarter against 3.08% in the March quarter. Net NPA came at 1.44% against 1.31% QoQ. Advances were at Rs 74,267 crore, down from Rs 75,455 crore in the same quarter last year.

NSDL’s profit in June quarter up by 15%

NSDL reported a consolidated net profit of Rs 90 crore in Q1FY26, marking an increase of 15% from Rs 78 crore during the same period last year. Revenue from operations, however, declined 7% annually to Rs 312 crore. EBITDA jumped 18% to Rs 95 crore and its EBITDA margin expanded by 660 basis points to 30.5%.

Apollo Hospitals’ profit up by 41.8% in June quarter

Overall performance was better than expectations. Revenue for the quarter grew 14.9% YoY at Rs 5842cr as compared to estimate of Rs 5772cr. Operating margin improved 130bps YoY at 14.6% as against expectation of 14%. Net profit was up 41.8% YoY at Rs 432.8cr. Other Income increased 8% YoY at Rs 40.2cr. Hospital revenue increased 11% YoY at Rs 2935 crore. EBITDA was up 15% YoY at Rs 718 crore. As on June 30, 2025, Apollo Hospitals had 8,030 operating beds across the network (excluding AHLL & managed beds). Overall occupancy for hospitals was at 65% vs. 68% in the same period in the previous year. EPS for the quarter stood at Rs 30.1 and it was at Rs 100.6 for FY25. At CMP, the stock trades at 44x FY27E EPS and 23x FY27E EV/EBITDA.

PI Industries’ profit in June quarter down by 11%

Operational performance was better than expectations. Revenue for the quarter declined 8% YoY at Rs 1900.5cr as compared to expectation of Rs 2110cr. Operating margin contracted 80bps YoY at 27.5% as against expectation of 27.7%. Net profit was down 11% YoY at Rs 400cr. Other Income increased 18% YoY at Rs 86cr. Domestic revenue grew 6% YoY at Rs 338.5cr. Exports business registered a decline of 10.7% YoY at Rs 1749cr.. Company targets commercialization of 8-10 new products in CSM exports during FY26. EPS for the quarter stood at Rs 26.36 and it was at Rs 109.4 for FY25. At CMP, the stock trades at 30.5x FY27E EPS.

Alkem Laboratories’ profit in June quarter up by 22%

Overall performance was better than expectations. Revenue for the quarter grew 11.2% YoY at Rs 3371cr as compared to estimate of Rs 3290cr. Operating margin improved 180bps YoY at 21.9% as against estimate of 20.8%. Gross margin was up 80bps at 65.3%. Net profit increased 22% YoY at Rs 664.3cr. Other Income was up 13.5% YoY at Rs 136.5cr. R&D expenses for the quarter was at Rs 119cr, or 3.5% of revenue in the quarter. India formulation sales increased 12% YoY at Rs 2265cr. US sales grew 8.8% YoY at Rs 698cr. RoW markets sales were up 9% YoY at Rs 356cr. As of June-2025, the company had filed 185 ANDAs and 2 NDAs with the US FDA. Of these, it had received approvals for 160 ANDAs (including 15 tentative approvals) and 2 NDAs. Company has net cash & equivalents of Rs 4870cr as on June-2025. EPS for the quarter stood at Rs 55.56 and it was at Rs 181 for FY25. At CMP, the stock trades at 23.5x FY27E EPS.

Natco Pharma’s profit down by 28% in June quarter

Overall performance was lower than expectations. Revenue for the quarter declined 2.5% YoY at Rs 1329cr as compared to estimate of Rs 1403cr. Operating margin slipped 1600bps YoY at 43% as against estimate of 47.3%. Net profit declined 28% YoY at Rs 480.7cr. Other Income was up 28% YoY at Rs 61.7cr. During the quarter, the business faced pricing pressure in the US portfolio and incurred increased R&D expenses on account of high value projects. EPS for the quarter stood at Rs 26.84 and it was at Rs 105.3 for FY25. At CMP, the stock trades at 17.8x FY27E EPS.

Marksans Pharma’s profit down by 34.3% in June quarter

Overall numbers were weak for the quarter. Revenue for the quarter increased 5% YoY at Rs 620cr as against estimate of Rs 655cr. Operating margin slipped 560bps YoY at 16.2% as against expectation of 19.5%. Gross margin improved 210bps YoY at 57.8%. Net profit declined 34.3% YoY at Rs 58.3cr. Other Income was down 62% YoY at Rs 5.65cr. US business increased 30.6% YoY at Rs 328cr. Europe sales declined 19% YoY at Rs 204cr. RoW sales remained flat at Rs 88cr. Cash Balance stood at Rs 711 crore as of June-2025. EPS for the quarter stood at Rs 1.29 and it was at Rs 8.4 for FY25. At CMP, the stock trades at 19.3x FY27E EPS.

Abbott India’s profit up by 11.8% in June quarter

Overall performance was slightly weak in the quarter. Revenue for the quarter grew 11.6% YoY at Rs 1738.4cr. EBITDA margin improved 50bps YoY at 25.6%. Net profit increased 11.8% YoY at Rs 366cr. Other Income was up 8.2% YoY at Rs 72.8cr.

Granules India’s profit down by 16.4% in June quarter

Overall results were lower than expectations. Revenue for the quarter grew 2.5% YoY at Rs 1210cr as against estimate of Rs 1257cr. EBITDA margin contracted 160bps YoY at 20.4% as against expectation of 21.3%. Gross margin expanded 590bps YoY at 64.9%. Net profit declined 16.4% YoY at Rs 112.6cr. Company reported exceptional loss of Rs 25.9cr in Q1FY26. Other Income stood at Rs 16.35cr vs. Rs 2.1cr in Q1FY25. Net debt stood at Rs 948cr and Net debt to EBITDA at 0.96x as of June-2025. It was at Rs 706cr as of March-2025. EPS for the quarter stood at Rs 4.64 and it was at Rs 20.68 for FY25. At CMP, the stock trades at 17x FY27E EPS.

Windlas Biotech’s profit up by 31% in June quarter

Revenue for the quarter grew 19.9% YoY at Rs 210cr. EBITDA margin expanded 70bps YoY at 12.6%. Net profit was up 31% YoY at Rs 17.7cr. Other Income increased 25% YoY at Rs 5.2cr.

Senores to acquire two products from Teva

Senores Pharmaceuticals Limited has signed agreement to acquire two products of US FDA approved Abbreviated New Drug Applications (ANDAs) from Teva Pharmaceuticals USA, Inc. The addressable opportunity of the acquired ANDAs in the USA is ~US$ 38 million as per IQVIA and ~US$ 120 million (MAT June 2025) as per the specialty data aggregator Symphony.

Zydus Lifesciences’ profit up by 3.3% in June quarter

Overall performance was lower than expectations in the quarter. Revenue grew 5.9% YoY at Rs 6574cr as against estimate of Rs 6704cr. EBITDA margin slipped 180bps YoY at 31.8% as against estimate of 32.2%. Gross margin was down 160bps YoY at 72.8%. R&D expenses for the quarter stood at Rs 486cr or 7.4% of sales as compared to Rs 393cr or 6.3% of sales in Q1FY25. Net profit was up 3.3% YoY at Rs 1467cr. Other Income surged 145% YoY at Rs 155cr. Domestic formulation business increased 8% YoY at Rs 1520cr. Consumer wellness revenue grew 2% YoY at Rs 855cr. Emerging Markets (EM) business reported 37% YoY growth to Rs 727cr. US formulations sales were up 3% YoY at Rs 3182cr, EPS for the quarter stood at Rs 14.58 and it was at Rs 44.97 for FY25. At CMP, the stock trades at 20.8x FY27E EPS.

Disclaimer : This content is only for informational purpose. It does not make any recommendation to act or invest. To get any error corrected, please write to content@hdfcsec.com.

Source: HDFC Securities Prime Research